.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
McKesson
Daiichi Sankyo
Chinese Patent Office
UBS
Deloitte
AstraZeneca
Healthtrust
Dow
Julphar

Generated: June 25, 2017

DrugPatentWatch Database Preview

Brexpiprazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for brexpiprazole and what is the scope of brexpiprazole patent protection?

Brexpiprazole
is the generic ingredient in one branded drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Brexpiprazole has twenty-six patent family members in twenty-five countries.

Two suppliers are listed for this compound.

Summary for Generic Name: brexpiprazole

Tradenames:1
Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list26
Clinical Trials: see list33
Patent Applications: see list40
Drug Prices:see low prices
DailyMed Link:brexpiprazole at DailyMed

Pharmacology for Ingredient: brexpiprazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka Pharm Co Ltd
REXULTI
brexpiprazole
TABLET;ORAL205422-004Jul 10, 2015RXYesNo7,888,362► SubscribeY ► Subscribe
Otsuka Pharm Co Ltd
REXULTI
brexpiprazole
TABLET;ORAL205422-004Jul 10, 2015RXYesNo8,618,109► Subscribe ► Subscribe
Otsuka Pharm Co Ltd
REXULTI
brexpiprazole
TABLET;ORAL205422-005Jul 10, 2015RXYesNo8,618,109► Subscribe ► Subscribe
Otsuka Pharm Co Ltd
REXULTI
brexpiprazole
TABLET;ORAL205422-006Jul 10, 2015RXYesYes7,888,362► SubscribeY ► Subscribe
Otsuka Pharm Co Ltd
REXULTI
brexpiprazole
TABLET;ORAL205422-003Jul 10, 2015RXYesNo7,888,362► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: brexpiprazole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,206,167Piperazine-substituted benzothiophenes for treatment of mental disorders► Subscribe
9,480,686Piperazine-substituted benzothiophenes for treatment of mental disorders► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: brexpiprazole

Country Document Number Estimated Expiration
Spain2358631► Subscribe
World Intellectual Property Organization (WIPO)2006112464► Subscribe
Japan4315393► Subscribe
Cyprus1111206► Subscribe
China101155804► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
AstraZeneca
Chinese Patent Office
Accenture
Colorcon
Julphar
Cipla
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot